Patrick Trieu-Cuot

Author PubWeight™ 84.13‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Mol Microbiol 2002 4.82
2 Accuracy of phenotypic and genotypic testing for identification of Streptococcus pneumoniae and description of Streptococcus pseudopneumoniae sp. nov. J Clin Microbiol 2004 3.96
3 Assembly and role of pili in group B streptococci. Mol Microbiol 2006 2.92
4 Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens. Nature 2009 2.68
5 Sorting sortases: a nomenclature proposal for the various sortases of Gram-positive bacteria. Res Microbiol 2005 2.20
6 Dual role for pilus in adherence to epithelial cells and biofilm formation in Streptococcus agalactiae. PLoS Pathog 2009 2.15
7 Formation of D-alanyl-lipoteichoic acid is required for adhesion and virulence of Listeria monocytogenes. Mol Microbiol 2002 2.15
8 Shaping a bacterial genome by large chromosomal replacements, the evolutionary history of Streptococcus agalactiae. Proc Natl Acad Sci U S A 2008 2.06
9 Taxonomic dissection of the Streptococcus bovis group by analysis of manganese-dependent superoxide dismutase gene (sodA) sequences: reclassification of 'Streptococcus infantarius subsp. coli' as Streptococcus lutetiensis sp. nov. and of Streptococcus bovis biotype 11.2 as Streptococcus pasteurianus sp. nov. Int J Syst Evol Microbiol 2002 2.01
10 TLR-independent type I interferon induction in response to an extracellular bacterial pathogen via intracellular recognition of its DNA. Cell Host Microbe 2008 1.98
11 CovS/CovR of group B streptococcus: a two-component global regulatory system involved in virulence. Mol Microbiol 2004 1.94
12 Multiplex PCR assay for rapid and accurate capsular typing of group B streptococci. J Clin Microbiol 2007 1.91
13 Genomic diversity and evolution within the species Streptococcus agalactiae. Microbes Infect 2006 1.86
14 The SrtA Sortase of Streptococcus agalactiae is required for cell wall anchoring of proteins containing the LPXTG motif, for adhesion to epithelial cells, and for colonization of the mouse intestine. Infect Immun 2005 1.75
15 Genome sequence of Streptococcus gallolyticus: insights into its adaptation to the bovine rumen and its ability to cause endocarditis. J Bacteriol 2010 1.64
16 Attenuated virulence of Streptococcus agalactiae deficient in D-alanyl-lipoteichoic acid is due to an increased susceptibility to defensins and phagocytic cells. Mol Microbiol 2003 1.53
17 The surface protein HvgA mediates group B streptococcus hypervirulence and meningeal tropism in neonates. J Exp Med 2010 1.51
18 Lipoproteins are critical TLR2 activating toxins in group B streptococcal sepsis. J Immunol 2008 1.40
19 Role of lipoteichoic acid in the phagocyte response to group B streptococcus. J Immunol 2005 1.35
20 Rapid detection of the "highly virulent" group B Streptococcus ST-17 clone. Microbes Infect 2006 1.31
21 Cell surface of Lactococcus lactis is covered by a protective polysaccharide pellicle. J Biol Chem 2010 1.29
22 Molecular dissection of the secA2 locus of group B Streptococcus reveals that glycosylation of the Srr1 LPXTG protein is required for full virulence. J Bacteriol 2009 1.27
23 Activation of the NLRP3 inflammasome by group B streptococci. J Immunol 2012 1.25
24 Respiration metabolism of Group B Streptococcus is activated by environmental haem and quinone and contributes to virulence. Mol Microbiol 2005 1.24
25 Genetic basis of antibiotic resistance in Streptococcus agalactiae strains isolated in a French hospital. Antimicrob Agents Chemother 2003 1.24
26 The putative glycosyltransferase-encoding gene cylJ and the group B Streptococcus (GBS)-specific gene cylK modulate hemolysin production and virulence of GBS. Infect Immun 2007 1.22
27 Streptococcus agalactiae GAPDH is a virulence-associated immunomodulatory protein. J Immunol 2007 1.18
28 Invasive group B streptococcal infections in infants, France. Emerg Infect Dis 2008 1.18
29 Capsular switching in group B Streptococcus CC17 hypervirulent clone: a future challenge for polysaccharide vaccine development. J Infect Dis 2012 1.17
30 Native valve endocarditis due to Enterococcus hirae. J Clin Microbiol 2002 1.15
31 The Group B Streptococcus NADH oxidase Nox-2 is involved in fatty acid biosynthesis during aerobic growth and contributes to virulence. Mol Microbiol 2006 1.07
32 D-alanylation of lipoteichoic acids confers resistance to cationic peptides in group B streptococcus by increasing the cell wall density. PLoS Pathog 2012 1.05
33 Atypical association of DDE transposition with conjugation specifies a new family of mobile elements. Mol Microbiol 2008 1.04
34 Molecular characterization of a Streptococcus gallolyticus genomic island encoding a pilus involved in endocarditis. J Infect Dis 2011 0.98
35 Group B streptococcus GAPDH is released upon cell lysis, associates with bacterial surface, and induces apoptosis in murine macrophages. PLoS One 2012 0.97
36 An in silico model for identification of small RNAs in whole bacterial genomes: characterization of antisense RNAs in pathogenic Escherichia coli and Streptococcus agalactiae strains. Nucleic Acids Res 2011 0.97
37 Rapid and accurate identification of human isolates of Pasteurella and related species by sequencing the sodA gene. J Clin Microbiol 2005 0.96
38 The 2-Cys peroxiredoxin alkyl hydroperoxide reductase c binds heme and participates in its intracellular availability in Streptococcus agalactiae. J Biol Chem 2010 0.95
39 Interaction with human plasminogen system turns on proteolytic activity in Streptococcus agalactiae and enhances its virulence in a mouse model. Microbes Infect 2007 0.93
40 Role of the Group B antigen of Streptococcus agalactiae: a peptidoglycan-anchored polysaccharide involved in cell wall biogenesis. PLoS Pathog 2012 0.91
41 Genetic basis of antibiotic resistance in clinical isolates of Streptococcus gallolyticus (Streptococcus bovis). Antimicrob Agents Chemother 2005 0.90
42 Fluoroquinolone-resistant group B streptococci in acute exacerbation of chronic bronchitis. Emerg Infect Dis 2008 0.90
43 Roles of environmental heme, and menaquinone, in streptococcus agalactiae. Biometals 2006 0.90
44 Inhibition of IL-10 production by maternal antibodies against Group B Streptococcus GAPDH confers immunity to offspring by favoring neutrophil recruitment. PLoS Pathog 2011 0.89
45 Group B Streptococcus surface proteins as major determinants for meningeal tropism. Curr Opin Microbiol 2011 0.89
46 The Abi-domain protein Abx1 interacts with the CovS histidine kinase to control virulence gene expression in group B Streptococcus. PLoS Pathog 2013 0.88
47 Adult zebrafish model of bacterial meningitis in Streptococcus agalactiae infection. Dev Comp Immunol 2012 0.88
48 Extracellular nucleotide catabolism by the Group B Streptococcus ectonucleotidase NudP increases bacterial survival in blood. J Biol Chem 2014 0.87
49 Effect of PhoP-PhoQ activation by broad repertoire of antimicrobial peptides on bacterial resistance. J Biol Chem 2011 0.87
50 Role of the Streptococcus agalactiae ClpP serine protease in heat-induced stress defence and growth arrest. Microbiology 2003 0.86
51 The GBS PI-2a pilus is required for virulence in mice neonates. PLoS One 2011 0.85
52 Epidemiologically and clinically relevant Group B Streptococcus isolates do not bind collagen but display enhanced binding to human fibrinogen. Microbes Infect 2012 0.85
53 Molecular mapping of the cell wall polysaccharides of the human pathogen Streptococcus agalactiae. Nanoscale 2014 0.84
54 FbsC, a novel fibrinogen-binding protein, promotes Streptococcus agalactiae-host cell interactions. J Biol Chem 2014 0.84
55 Group B Streptococcus hijacks the host plasminogen system to promote brain endothelial cell invasion. PLoS One 2013 0.84
56 TLR2-induced IL-10 production impairs neutrophil recruitment to infected tissues during neonatal bacterial sepsis. J Immunol 2013 0.84
57 Rga, a RofA-like regulator, is the major transcriptional activator of the PI-2a pilus in Streptococcus agalactiae. Microb Drug Resist 2012 0.83
58 Comparison of the Diversilab® system with multi-locus sequence typing and pulsed-field gel electrophoresis for the characterization of Streptococcus agalactiae invasive strains. J Microbiol Methods 2011 0.82
59 SecA localization and SecA-dependent secretion occurs at new division septa in group B Streptococcus. PLoS One 2013 0.80
60 Analysis of the Streptococcus agalactiae exoproteome. J Proteomics 2013 0.80
61 Comparative evaluation of VITEK 2 for antimicrobial susceptibility testing of group B Streptococcus. J Antimicrob Chemother 2007 0.79
62 Molecular basis for different levels of tet(M) expression in Streptococcus pneumoniae clinical isolates. Antimicrob Agents Chemother 2012 0.79
63 Genetics of streptococci, lactococci, and enterococci: review of the sixth international conference. J Bacteriol 2002 0.78
64 Construction of isogenic mutants in Streptococcus gallolyticus based on the development of new mobilizable vectors. Res Microbiol 2013 0.78
65 [A breakthrough in the understanding of neonatal group B streptococcus meningitis]. Med Sci (Paris) 2011 0.75
66 Corrigendum: Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline. Nat Commun 2015 0.75
67 [Why group A streptococci is strictly pathogen in human? A first answer given by a humanized mouse model]. Med Sci (Paris) 2005 0.75